High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules
- PMID: 2994035
- PMCID: PMC390596
- DOI: 10.1073/pnas.82.17.5588
High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules
Abstract
Proteins that have been modified by long-term exposure to glucose accumulate advanced glycosylation end products (AGE) as a function of protein age. In these studies, we have characterized the interaction of AGE-protein with mouse peritoneal macrophages, using AGE-modified bovine serum albumin (AGE-BSA, prepared by incubation with glucose) as a probe. AGE-BSA was specifically bound to cells at 4 degrees C and was taken up and degraded at 37 degrees C; these processes were concentration dependent and saturable. Competition experiments with AGE-BSA, BSA incubated with phosphate-buffered saline rather than glucose, and yeast mannan demonstrated that macrophages specifically recognize AGE on proteins by a receptor that is completely distinct from the mannose/fucose receptor. Scatchard analysis of AGE-BSA binding data indicated that there are approximately 1.06 X 10(5) receptors per macrophage, with an affinity constant of 1.75 X 10(-11) M. Specific binding of AGE-BSA to the macrophage receptor was competitively inhibited by BSA that had been chemically coupled to a synthetic analogue of the specific AGE, 2-(2-furoyl)-4(5)-(2-furanyl)-1H-imidazole (FFI-BSA). FFI-BSA was also taken up by macrophages in a concentration-dependent, saturable manner. Prior incubation of macrophages with AGE-BSA failed to influence the subsequent uptake and degradation of added AGE-BSA. Thus, the AGE receptor does not appear to be down-regulated by exposure to AGE-proteins. Results from these studies suggest that AGE could act in vivo as a specific signal for recognition and degradation of senescent macromolecules. Incomplete removal of AGE-proteins by macrophages may ultimately give rise to some of the physiologic changes that occur with normal aging.
Similar articles
-
Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages. A model for turnover of aging cells.J Exp Med. 1987 Aug 1;166(2):539-49. doi: 10.1084/jem.166.2.539. J Exp Med. 1987. PMID: 3598465 Free PMC article.
-
Endocytic uptake of nonenzymatically glycosylated proteins is mediated by a scavenger receptor for aldehyde-modified proteins.J Biol Chem. 1988 Oct 15;263(29):14819-25. J Biol Chem. 1988. PMID: 2844787
-
Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo.Diabetes. 1988 Apr;37(4):456-61. doi: 10.2337/diab.37.4.456. Diabetes. 1988. PMID: 2837419
-
Macrophage receptor-mediated processing and regulation of advanced glycosylation endproduct (AGE)-modified proteins: role in diabetes and aging.Prog Clin Biol Res. 1989;304:205-18. Prog Clin Biol Res. 1989. PMID: 2550952 Review.
-
Receptor-mediated interactions of advanced glycosylation end products with cellular components within diabetic tissues.Diabetes. 1992 Oct;41 Suppl 2:52-6. doi: 10.2337/diab.41.2.s52. Diabetes. 1992. PMID: 1326453 Review.
Cited by
-
Effect of Type 2 Diabetes Mellitus and Diabetic Nephropathy on IgG Pharmacokinetics and Subcutaneous Bioavailability in the Rat.AAPS J. 2015 Jul;17(4):965-75. doi: 10.1208/s12248-015-9771-3. Epub 2015 Apr 30. AAPS J. 2015. PMID: 25924888 Free PMC article.
-
From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain.J Neural Transm (Vienna). 2006 Nov;113(11):1671-7. doi: 10.1007/s00702-006-0591-6. Epub 2006 Oct 23. J Neural Transm (Vienna). 2006. PMID: 17053873 Review.
-
Transcytosis and catabolism of antibody.Immunol Res. 2002;25(2):97-113. doi: 10.1385/IR:25:2:097. Immunol Res. 2002. PMID: 11999172 Review.
-
Differential expression of fructosyllysine-specific receptors on monocytes and macrophages and possible pathophysiological significance.Diabetologia. 1996 Oct;39(10):1140-7. doi: 10.1007/BF02658499. Diabetologia. 1996. PMID: 8897000
-
Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.J Clin Invest. 1997 Feb 1;99(3):457-68. doi: 10.1172/JCI119180. J Clin Invest. 1997. PMID: 9022079 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical